Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis

Objective To investigate the changes in serum levels of M30,M65,and interleukin- 17( IL- 17) and their clinical significance in patients with acute pancreatitis. Methods A total of 126 patients with acute pancreatitis who were admitted to our hospital from December 2009 to December 2013 were selected,and according to clinical diagnosis,they were divided into mild acute pancreatitis group( 82 patients) and severe acute pancreatitis group( 44 patients). A total of 107 healthy subjects who underwent physical examination during the same period of time were enrolled as the control group. On days 1,2,and 4,the serum levels of M30,M65,and IL- 17 were measured,and M30 / M65 ratio was calculated. Comparison of coutinous data between multiple groups was made by ANOVA and pairwise comparison between any two groups was made by SNK- q test,comparison between two groups was made by independent- sample t test,while comparison of categorical data by chisquare test. Results On days 1,2,and 4,the severe acute pancreatitis group and mild acute pancreatitis group had significantly higher serum levels of M30,M65,and IL- 17( P < 0. 05),and a significantly lower M30 / M65 ratio( P <0. 001),as compared with the healthy controls. On days 1,2,and 4,the severe acute pancreatitis group had significantly higher serum levels of M30 and M65 than the mild acute pancreatitis group( P < 0. 001); on day 1,the severe acute pancreatitis group had a significantly lower M30 / M65 ratio than the mild acute pancreatitis group( P < 0. 001); the serum level of IL- 17 showed no significant difference between the two groups( P > 0. 05). M65 and IL- 17 had high sensitivity and specificity in the diagnosis of acute pancreatitis. Conclusion The serum levels of M65 and IL- 17 and M30 / M65 ratio at 24 hours after the attack of acute pancreatitis can be used as the serological biomarkers for early evaluation of the severity of acute pancreatitis.